I-TTBB CAS 124750-51-2 Purity >96.0% (HPLC) I-Irbesartan Intermediate Factory

Incazelo emfushane:

Igama: 5-(4′-Bromomethyl-1,1′-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole

Amazwi afanayo: TTBB

I-CAS: 124750-51-2

Ubumsulwa: >96.0% (HPLC)

Ukubukeka: Impushana Emhlophe Ukuya Kucishe Emhlophe

I-Irbesartan emaphakathi (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com   


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali 5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Omqondofana I-TTBB;I-BBTT;5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazole;I-N-(Triphenylmethyl)-5-(4'-Bromomethylbiphenyl-2-yl-)tetrazole;Ukungcola kwe-Olmesartan 12;I-Losartan Bromo N1-Trityl Ukungcola
Inombolo ye-CAS 124750-51-2
Inombolo yeCAT I-RF-PI1878
Isimo Sesitoko Esitokweni, Amandla Okukhiqiza 150MT/Ngonyaka
I-Molecular Formula I-C33H25BrN4
Isisindo samangqamuzana 557.48
I-Melting Point 152.0~155.0℃
Ukuminyana 1.28±0.10 g/cm3
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kucishe Emhlophe
Ukuhlanzeka / Indlela Yokuhlaziya >96.0% (HPLC)
Ukulahlekelwa Ekumisweni <0.50%
Ukungcola A <2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Ukungcola B <2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
I-Infrared Spectrum Ivumelana Nesakhiwo
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Irbesartan ephakathi (CAS: 138402-11-6);I-Olmesartan Medoxomil Ukungcola

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) iphakathi kwe-Irbesartan (CAS: 138402-11 -6).I-Irbesartan isetshenziselwa ukwelapha umfutho wegazi ophakeme, kanye ne-nephropathy yesifo sikashukela ene-serum creatinine ephakeme kanye ne-proteinuria (> 300 mg / ngosuku) ezigulini ezinesifo sikashukela sohlobo 2 kanye nomfutho wegazi ophakeme.I-Irbesartan nayo isetshenziswa njenge-ejenti yomugqa wesibili ekwelapheni ukuminyana.I-Irbesartan iyi-angiotensin II receptor antagonist esetshenziswa ikakhulukazi ekwelapheni umfutho wegazi ophakeme.Yasungulwa ngabakwaSanofi Research (manje abayingxenye yeSanofi-Aventis).Imakethwa ngokuhlanganyela yi-Sanofi-Aventis kanye ne-Bristol-Myers Squibb ngaphansi kwamagama okuhweba i-Aprovel, Karvea, ne-Avapro.

Bhala umyalezo wakho lapha futhi usithumelele wona